Evidence map›Paper›PMID 40599380›Full record

ArticleFrontiers in aging neuroscience2025

Effects of West Nile virus on behavioral and cognitive performance, cortical Aβ pathology, viral loads, and immune measures of middle-aged NL-G-F/E3 and NL-G-F/E4 mice.

Abigail O'Niel, Christopher J Parkins, Alexandra Pederson, Elizabeth Saltonstall, Emily Bunnell, Ria Aggarwal, Phoebe Sandholm, Kat Kessler, Henry F Harrison, Jessica L Smith and 2 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Abigail O'NielDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Christopher J ParkinsVaccine and Gene Therapy Center, Oregon Health and Science University, Portland, OR, United States.
Alexandra PedersonDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Elizabeth SaltonstallDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Emily BunnellDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Ria AggarwalDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Phoebe SandholmDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Kat KesslerDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.
Henry F HarrisonVaccine and Gene Therapy Center, Oregon Health and Science University, Portland, OR, United States.
Jessica L SmithVaccine and Gene Therapy Center, Oregon Health and Science University, Portland, OR, United States.
Alec J HirschVaccine and Gene Therapy Center, Oregon Health and Science University, Portland, OR, United States.
Jacob RaberDepartment of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, United States.

Funding

Neuroscience of Aging, Neurodegeneration and Alzheimer’s DiseaseT32AG055378 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOB RABER, HENRYK F URBANSKI · 2018 to 2026
$4.3M
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathologyR21AG079158 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HIRSCH, ALEC J, RABER, JACOB · 2023 to 2024
$424k
NIA NIH HHS R21 AG079158NIA NIH HHS T32 AG055378
6 · The paper itself

Abstract

Introduction: West Nile Virus (WNV) can cause severe and long-lasting neurological disease and results in some neuropathology and neuroinflammation seen in Alzheimer's disease (AD). Exposure to WNV might impact AD-relevant behavioral and cognitive performance and neuropathology via AD-susceptibility genes (i.e., E4) and by inducing neuroinflammation (i.e., increases in TCR-α, IFN-γ, TNF-α, and CXCL- 10). There are three human apolipoprotein E (E) isoforms, which play a role in cholesterol metabolism: E2, E3, and E4. Compared to E3, E4 is an AD risk factor. Methods: We crossed knock-in (KI) mice expressing human amyloid precursor protein (APP) containing the dominant NL-G-F mutations with human apoE targeted replacement (TR) mice and used middle-aged NL-G-F/E3 and NL-G-F/E4 mice to assess the role of prior WNV (subtype Kunjin virus) (KUNV) exposure on hAPP/Aβ-induced behavioral alterations, cognitive injury, circadian body temperatures, viral loads, neuropathology, and transcript levels of four immune measures important in the detrimental effects of KUNV on brain function. Results: KUNV affected physiological, behavioral, cognitive, amyloid pathology, viral load, and immune measures in middle aged NL-G-F mice in an apoE isoform-dependent fashion. NL-G-F/E4 mice were more susceptible to KUNV induced cognitive injury and prolonged viral load in the cortex. Discussion: These results support an important apoE isoform-dependent role in modulating phenotypes in the NL-G-F AD mouse model following WNV exposure.

Indexed as

amyloid pathologyamyloid precursor proteinapolipoprotein Ebehavioral testingbody temperaturecognitive testingviral loadWest Nile virus

Identifiers

PMID40599380
PMCPMC12209204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.